Konferenser och symposier Symposium in Network Analysis in Personalized Medicine
| 8:30 | Registration & Coffee |
| 9:00-9:15 |
Welcome Dr. Ole Petter Ottersen, President Karolinska Institutet |
| 9:15-9:45 |
Keynote Lecture: Network Medicine: New Approach to Diagnosis and Treatment of Disease Dr. Joseph Loscalzo, Harvard Medical School, USA |
| 9:45-10:30 |
Keynote Lecture: Taming Complexity: Controlling Networks Dr. Albert-László Barabási, Northeastern University, USA |
| Coffee | |
| 10:50-11:20 |
Common-Mechanism Based Network Pharmacology and Drug Repurposing Dr. Harald Schmidt, Maastricht University, Netherlands |
| 11:20-11:50 |
Network medicine and data analysis in epigenetics: application in personalised medicine Dr. Lucia Altucci, Università degli Studi della Campania Luigi Vanvitelli, Italy |
| 12:00-13:00 |
Lunch |
| 13:00-13:30 |
Whole genome sequencing for diagnosis and discovery of inherited diseases Dr. Anna Wedell, Karolinska Institutet & Karolinska University Hospital |
| 13:30-14:00 |
Translating precision medicine into clinical utility in hematology Dr. Richard Rosenquist Brandell, Karolinska Institutet |
| 14:00-14:30 |
Next step to improve precision medicine: connecting genotype with molecular phenotype Dr. Janne Lehtiö, Karolinska Institutet & Science For Life Laboratory |
| 14:30-15:00 |
Genetic Identification of Cell Types Underlying Brain Complex Traits Dr. Jens Hjerling-Leffler, Karolinska Institutet |
| 15:00-15:30 | Coffee |
| 15:30-16:00 |
The ALASCCA Trial – integrating personalized medicine and research into clinical praxis Dr. Anna Martling, Karolinska Institutet |
| 16:00-16:30 |
Concluding remarks and discussion on the future developments Dr. Joseph Loscalzo, Harvard Medical School, USA Dr. Paolo Parini, Karolinska Institutet |
The programme is continually updated. Please register here latest by May 15 and please note that registration is compulsory. For more information please contact: Pernilla Witte, pernilla.witte@ki.se
More information about the International Network Medicine Consortium.